Representation of Patients With Chronic Kidney Disease in Trials of Cancer Therapy
This study characterizes the exclusion of patients with chronic kidney disease (CKD) in randomized clinical trials of drug treatment for bladder, breast, colorectal, lung, and prostate cancer.
Source: JAMA - Category: General Medicine Source Type: research
More News: Bladder Cancer | Cancer | Cancer & Oncology | Cancer Therapy | Chronic Kidney Disease | Clinical Trials | Colorectal Cancer | General Medicine | Prostate Cancer | Study | Urology & Nephrology